These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31157502)

  • 41. Endemic Burkitt lymphoma of maxillofacial region: results of induction treatment with cyclophosphamide plus methotrexate in West Africa.
    Béogo R; Nacro B; Ouédraogo D; Ouoba K
    Pediatr Blood Cancer; 2011 Jul; 56(7):1068-70. PubMed ID: 21344617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemotherapy Treatments for Burkitt Lymphoma: Systematic Review of Interventional Studies.
    Della Rocca AM; Leonart LP; Ferreira VL; Tonin FS; Steffenello-Durigon G; Del Moral JAG; Fernandez-Llimos F; Pontarolo R
    Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):514-525. PubMed ID: 33947633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
    Shimada K; Yamaguchi M; Atsuta Y; Matsue K; Sato K; Kusumoto S; Nagai H; Takizawa J; Fukuhara N; Nagafuji K; Miyazaki K; Ohtsuka E; Okamoto M; Sugita Y; Uchida T; Kayukawa S; Wake A; Ennishi D; Kondo Y; Izumi T; Kin Y; Tsukasaki K; Hashimoto D; Yuge M; Yanagisawa A; Kuwatsuka Y; Shimada S; Masaki Y; Niitsu N; Kiyoi H; Suzuki R; Tokunaga T; Nakamura S; Kinoshita T
    Lancet Oncol; 2020 Apr; 21(4):593-602. PubMed ID: 32171071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca].
    Madani A; Benhmiddoune L; Zafad S; Harif M; Quessar A; Benchekroun S
    Bull Cancer; 2005 Feb; 92(2):193-8. PubMed ID: 15749649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.
    Diviné M; Casassus P; Koscielny S; Bosq J; Sebban C; Le Maignan C; Stamattoulas A; Dupriez B; Raphaël M; Pico JL; Ribrag V; ;
    Ann Oncol; 2005 Dec; 16(12):1928-35. PubMed ID: 16284057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study.
    Buckle G; Maranda L; Skiles J; Ong'echa JM; Foley J; Epstein M; Vik TA; Schroeder A; Lemberger J; Rosmarin A; Remick SC; Bailey JA; Vulule J; Otieno JA; Moormann AM
    Int J Cancer; 2016 Sep; 139(6):1231-40. PubMed ID: 27136063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inferior prognosis of gastric involvement in patients with gastrointestinal Burkitt Lymphoma.
    Xie Y; Jia M; Shi J; Tao Y
    Cancer Med; 2020 May; 9(9):3107-3114. PubMed ID: 32160410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.
    Schwenn MR; Blattner SR; Lynch E; Weinstein HJ
    J Clin Oncol; 1991 Jan; 9(1):133-8. PubMed ID: 1985162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Skin involvement in Burkitt's lymphoma.
    Thakkar D; Lipi L; Misra R; Yadav SP
    Hematol Oncol Stem Cell Ther; 2018 Dec; 11(4):251-252. PubMed ID: 29397332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Long term efficacy of COPADM regimen in the treatment of 20 patients with Burkitt lymphoma].
    Yang D; Wang P; Chen J; Li CX; Zhang Y; Chen XC; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2018 Aug; 39(8):645-649. PubMed ID: 30180465
    [No Abstract]   [Full Text] [Related]  

  • 51. Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.
    Jost LM; Jacky E; Dommann-Scherrer C; Honegger HP; Maurer R; Sauter C; Stahel RA
    Ann Oncol; 1995 May; 6(5):445-51. PubMed ID: 7545428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Outcome of children and adolescents with Burkitt lymphoma and diffuse large B cell lymphoma treated with a modified NHL-BFM-90 protocol].
    Sun XF; Zhen ZJ; Xia Y; Lin SX; Zhu J; Wang J; Lu SY; Sun FF; Chen Y; Zhang F; Cai RQ; Li PF
    Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1032-7. PubMed ID: 24369160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rescue chemotherapy for patients with resistant or relapsed endemic Burkitt's lymphoma.
    Hesseling PB; Molyneux E; Kamiza S; Broadhead R
    Trans R Soc Trop Med Hyg; 2008 Jun; 102(6):602-7. PubMed ID: 18417177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infection.
    Orem J; Maganda A; Mbidde EK; Weiderpass E
    Pediatr Blood Cancer; 2009 Apr; 52(4):455-8. PubMed ID: 18802952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Burkitt's lymphoma treatment in a rural hospital in Sierra Leone.
    San Roman M; Aguilo F; Clapes M; Sheku M; Dawoh P; Mora J; Cruz O
    Trans R Soc Trop Med Hyg; 2013 Oct; 107(10):653-9. PubMed ID: 24021903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience.
    Ziegler JL
    N Engl J Med; 1977 Jul; 297(2):75-80. PubMed ID: 865579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols.
    Tauro S; Cochrane L; Lauritzsen GF; Baker L; Delabie J; Roberts C; Mahendra P; Holte H
    Am J Hematol; 2010 Apr; 85(4):261-3. PubMed ID: 20201088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective.
    Hoffmann C; Wolf E; Wyen C; Fätkenheuer G; Van Lunzen J; Stellbrink HJ; Stoehr A; Plettenberg A; Jaeger H; Noppeney R; Hentrich M; Goekbuget N; Hoelzer D; Horst HA
    Leuk Lymphoma; 2006 Sep; 47(9):1872-80. PubMed ID: 17065000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels.
    Kim HD; Cho H; Kim S; Lee K; Kang EH; Park JS; Park CS; Huh J; Ryu JS; Lee SW; Yoon DH; Kim SJ; Ko YH; Kim WS; Suh C
    Cancer Res Treat; 2021 Jul; 53(3):847-856. PubMed ID: 33332932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.